Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of February 2019. The report was signed on February 28, 2019, by Zhang Qisen (Johnson), the Chief Financial Officer. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing indicates that the company files annual reports under Form 20-F.
Financial Metrics
The provided filing text does not contain specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a cover sheet referencing an attached press release (Exhibit 99.1) but does not include the content of that exhibit.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods. No comparative financial data or operational updates are present in the provided content.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risk factors, contingencies, or unusual items. These details are likely contained within the referenced Exhibit 99.1 (Press Release), which is not included in the input text.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Press Release) to obtain the actual financial results or corporate announcements intended for this filing.
- Confirm the identity of the registrant as Hexindai Inc., noting the discrepancy with the "Akso Health Group" name in the request metadata.
- Check subsequent filings or the referenced press release for specific revenue, profit, or liquidity figures, as they are absent from this cover document.